Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
79.80    2.10 (2.70%)
Bid:
79.90
Ask:
81.20
Spread: 1.30 (1.627%)
Market Cap: £130.83m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Director/PDMR Shareholding

Today 15:53

RNS Number : 0266K
Synthomer PLC
26 June 2026
 

LEI: 213800EHT3TI1KPQQJ56

Notification of Transactions by Persons Discharging Managerial Responsibilities

The Company makes the following notification in respect of awards granted to Michael Willome, Chief Executive Officer.

The Company has granted: (i) awards to Michael Willome under the Synthomer Performance Share Plan (the "PSP"); and (ii) a one-off retention award, as approved by shareholders at the Company's 2026 AGM.

(i) Performance Share Plan (PSP) Awards

The PSP awards are split between a primary award and an additional award, in line with the Directors' Remuneration Policy. Both awards are subject to performance conditions, measured over the performance period from 1 January 2026 to 31 December 2028. The performance conditions, weightings and targets for the primary PSP awards in 2026 are set out below:

· EPS (10%): threshold vesting at 1p; maximum vesting at 20.1p

· Relative TSR (50%): measured against the FTSE 250 (excluding investment trusts and financial services companies), with threshold vesting at median performance and maximum vesting at upper quartile

· Leverage (20%): targets will be disclosed retrospectively given their commercially sensitive nature

· Carbon reduction (10%): threshold vesting at 29.4%; maximum vesting at 37.8%

· Vitality Index (10%): threshold vesting at 12%; maximum vesting at 15%

The additional award is based on relative TSR, with threshold vesting beginning at upper quartile performance and maximum vesting at upper decile. The PSP awards were granted on 24 June 2026, with the number of shares determined by reference to the average share price over the five dealing days to 8 May 2026, being the first trading period following the announcement of the Company's 2025 results and the end of the closed period.

The Remuneration Committee selected this approach to apply the Company's standard five-day averaging methodology to the first appropriate trading window following the announcement of both the Group's results and refinancing, thereby providing an appropriate basis for the grant in the circumstances.

(ii) One-Off Retention Award

In addition, the Company has granted a one-off retention award to Michael Willome, following shareholder approval at the 2026 AGM.

As described in the resolution approved by shareholders at the 2026 AGM, the retention award comprises:

· 500,000 ordinary shares, vesting after two years, subject to the Company's share price reaching at least 140p over a consecutive 30-day trading period during the vesting period; and

· 500,000 ordinary shares, vesting after three years, subject to the Company's share price reaching at least 175p over a consecutive 30-day trading period during the vesting period.

Vesting of the retention award is subject to continued employment and the Company's standard malus and clawback provisions and other customary terms.

Full details of the PSP and retention awards will be disclosed in the Company's 2026 Directors' Remuneration Report.

 

Details of the transactions are set out below.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Michael Willome

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Synthomer plc

b)

 

LEI

 

 

213800EHT3TI1KPQQJ56

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(i)

Transaction 1 - PSP Awards

a)

 

Description of the financial instrument, type of instrument

 

 

Identification code

Ordinary shares of 1 pence each in Synthomer plc

 

 

 

GB00BNTVWJ75

b)

 

Nature of the transaction

 

 

Grant of nil cost options under the Synthomer Performance Share Plan

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

2,096,474

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A - single transaction

 

Nil

 

 

e)

 

Date of the transaction

 

 

24 June 2026

f)

 

Place of the transaction

N/A - outside a trading venue

(ii)

Transaction 2 - One-Off Retention Award (2-Year Tranche)

a)

 

Description of the financial instrument, type of instrument

 

 

Identification code

Ordinary shares of 1 pence each in Synthomer plc

 

 

 

GB00BNTVWJ75

b)

 

Nature of the transaction

 

 

Grant of a nil cost conditional share award subject to share price performance conditions

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

500,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A - single transaction

 

Nil

 

 

e)

 

Date of the transaction

 

 

24 June 2026

f)

 

Place of the transaction

N/A - outside a trading venue

(iii)

Transaction 3 - One-Off Retention Award (3-Year Tranche)

a)

 

Description of the financial instrument, type of instrument

 

 

Identification code

Ordinary shares of 1 pence each in Synthomer plc

 

 

 

GB00BNTVWJ75

b)

 

Nature of the transaction

 

 

Grant of a nil cost conditional share award subject to share price performance conditions

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

500,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A - single transaction

 

Nil

 

 

e)

 

Date of the transaction

 

24 June 2026

f)

Place of the transaction

N/A - outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALKKASEKEFA
Date   Source Headline
26th Jun 20263:53 pmRNSDirector/PDMR Shareholding
22nd Jun 20261:31 pmRNSResults of AGM
22nd Jun 20267:00 amRNSAGM trading statement
19th Jun 20267:00 amRNSDivestment of Acrylate Monomers
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.